U.S. RESEARCH ROUNDUP-Factset, Lensar, Starbucks

Reuters15:36
U.S. RESEARCH ROUNDUP-Factset, Lensar, Starbucks

March 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Factset, Lensar and Starbucks on Wednesday.

HIGHLIGHTS

* Factset FDS.N: RBC cuts target price to $243 from $320

* Lensar Inc LNSR.O: BTIG raises to buy from neutral

* Sable Offshore Corp SOC.N: Gerdes Energy Research cuts to neutral from buy

* Starbucks SBUX.O: RBC cuts to sector perform from outperform

* Weatherford International Plc WFRD.O: RBC initiates coverage with outperform rating

Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.

* Aldeyra Therapeutics Inc ALDX.O: H.C. Wainwright cuts to neutral from buy

* Aldeyra Therapeutics Inc ALDX.O: H.C. Wainwright cuts target price to $2 from $10

* Alto Neuroscience Inc ANRO.N: Baird raises target price to $41 from $22

* BitGo Holdings Inc BTGO.N: Citigroup cuts target price to $17 from $18

* Brightspring Health Services Inc BTSG.O: TD Cowen raises target price to $60 from $49

* Cal-Maine Foods Inc CALM.O: Stephens raises target price to $90 from $85

* Constellation Brands Inc STZ.N: Citigroup raises to buy from neutral

* Constellation Brands Inc STZ.N: Citigroup raises target price to $175 from $155

* Dakota Gold Corp. DC.A: H.C. Wainwright raises target price to $10.5 from $9.75

* Docusign Inc DOCU.O: JP Morgan cuts target price to $65 from $78

* Evommune Inc EVMN.N: H.C. Wainwright cuts target price to $50 from $65

* Factset FDS.N: RBC cuts target price to $243 from $320

* Galaxy Digital Inc GLXY.O: Citigroup raises target price to $28 from $25

* Gemini Space Station Inc GEMI.O: Citigroup cuts to sell from neutral

* Gemini Space Station Inc GEMI.O: Citigroup cuts target price to $5.5 from $13

* Grail Inc GRAL.O: TD Cowen raises to buy from hold

* Grail Inc GRAL.O: TD Cowen cuts target price to $65 from $114

* Healthequity Inc HQY.O: RBC cuts target price to $100 from $110

* Highpeak Energy Inc HPK.O: Gerdes Energy Research cuts to sell from neutral

* IBM IBM.N: JP Morgan cuts target price to $283 from $317

* Lennar Corp LEN.N: KBW cuts target price to $105 from $115

* Lensar Inc LNSR.O: BTIG raises to buy from neutral

* Micron Technology Inc MU.O: Bernstein raises target price to $510 from $330

* Navient Corp NAVI.O: Jefferies cuts target price to $9 from $13

* Netflix Inc NFLX.O: Citigroup resumes coverage with buy rating; price target $115

* Oklo Inc OKLO.N: Canaccord Genuity cuts target price to $125 from $175

* Rhythm Pharmaceuticals Inc RYTM.O: H.C. Wainwright cuts target price to $100 from $110

* Riot Platforms Inc RIOT.O: Citigroup cuts target price to $21 from $23

* Sable Offshore Corp SOC.N: Gerdes Energy Research cuts to neutral from buy

* Starbucks SBUX.O: RBC cuts to sector perform from outperform

* Strategy MSTR.O: Citigroup cuts target price to $260 from $325

* Topbuild Corp BLD.N: D.A. Davidson cuts target price to $465 from $485

* Weatherford International Plc WFRD.O: RBC initiates coverage with outperform rating

* Weatherford International Plc WFRD.O: RBC initiates coverage with target price $105

(Compiled by Bengaluru Newsroom)

((Diaries@thomsonreuters.com))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment